{"id":"CHEMBL1088762","canonicalSmiles":"COc1ccc(S(=O)(=O)N2CCN(S(=O)(=O)c3ccc4c(c3)OCCO4)CC2)cc1","inchiKey":"HMGDKYUJSFVHIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1088762","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26668724","57646205","57646206","847943"],"drugbank":["DB07697"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1090479","canonicalSmiles":"CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1","inchiKey":"QTBWCSQGBMPECM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-1070916","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK 1070916A","GSK1070916","Gsk-1070916"],"count":1,"linkedTargets":{"rows":["ENSG00000178999","ENSG00000105146"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1095284","canonicalSmiles":"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3c[nH]nn3)CS[C@H]12)c1ccc(O)cc1","inchiKey":"UOCJDOLVGGIYIQ-PBFPGSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFATRIZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BL-S640","Cefatrizine"],"crossReferences":{"PubChem":["124896641","144206927"],"Wikipedia":["Cefatrizine"],"drugbank":["DB13266"]},"childChemblIds":["CHEMBL3115472"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1095292","canonicalSmiles":"CC[N+](C)(C)Cc1ccccc1Br.Cc1ccc(S(=O)(=O)[O-])cc1","inchiKey":"KVWNWTZZBKCOPM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BRETYLIUM TOSYLATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1199080","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bretylium tosylate","Bretylol"],"synonyms":["ASL-603","Bretylium tosilate","Bretylium tosylate"],"crossReferences":{"DailyMed":["bretylium%20tosylate"],"PubChem":["11111997","11111998","50104303","85231294","855621"],"chEBI":["3173"]},"count":1,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0004269"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for cardiac arrhythmia."}
{"id":"CHEMBL1103","canonicalSmiles":"O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1","inchiKey":"PLHJDBGFXBMTGZ-WEVVVXLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURAZOLIDONE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Furall","Furoxone"],"synonyms":["Furazolidone","NSC-6469","Nifurazolidone"],"crossReferences":{"PubChem":["144205055","170464641","26749310","29215179"],"Wikipedia":["Furazolidone"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL1160571","canonicalSmiles":"O=P(O)(O)OP(=O)(O)O","inchiKey":"XPPKVPWEQAFLFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROPHOSPHORIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4253134"],"Wikipedia":["Pyrophosphoric_acid"],"drugbank":["DB04160"],"chEBI":["29888"]},"childChemblIds":["CHEMBL3184949","CHEMBL450079","CHEMBL2028376"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1169","canonicalSmiles":"Nc1ccc(C(=O)O)c(O)c1","inchiKey":"WUBBRNOQWQTFEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOSALICYLIC ACID","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Granupas","Parasal","Paser","Rezipas"],"synonyms":["4-aminosalicylic acid","Aminosalicylic Acid","Aminosalicylic acid","Aminosalicylic acid resin complex","NSC-2083","P-aminosalicylic acid","Para-aminosalicylic acid","Pas","Paskalium","Teebacin"],"crossReferences":{"DailyMed":["aminosalicylic%20acid"],"PubChem":["29215427","56422457","855553"],"Wikipedia":["4-Aminosalicylic_acid"],"drugbank":["DB00233"],"chEBI":["27565"]},"childChemblIds":["CHEMBL2105983","CHEMBL2096646","CHEMBL1343453","CHEMBL1200584","CHEMBL1200966","CHEMBL1378207"],"count":4,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for tuberculosis and has 3 investigational indications."}
{"id":"CHEMBL1181731","canonicalSmiles":"COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/CCCCCCOc2ccc(Cl)cc2)NC#N)cc1","inchiKey":"RXXJCNMVVRGOJB-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGLARINAD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL190412"],"linkedTargets":{"rows":["ENSG00000105835"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1189025","canonicalSmiles":"C=C(Br)C(=O)Nc1cc(C(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cc(C(=O)NCCN=C(N)N)n(C)c4)n(C)c3)n(C)c2)n(C)c1","inchiKey":"RXOVOXFAAGIKDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROSTALLICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brostallicin"],"crossReferences":{"drugbank":["DB06598"]},"childChemblIds":["CHEMBL537929"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1190","canonicalSmiles":"C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C","inchiKey":"MTCUAOILFDZKCO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECAMETHONIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Decamethonium","Syncurine"],"crossReferences":{"PubChem":["11111046","11111047","26756594","90341654"],"drugbank":["DB01245"],"chEBI":["41934"]},"childChemblIds":["CHEMBL1134"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL119423","canonicalSmiles":"Sc1[nH]cnc2nncc1-2","inchiKey":"PYAOPMWCFSVFOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TISOPURINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exuracid"],"synonyms":["Tisopurine"],"crossReferences":{"drugbank":["DB13807"]},"count":1,"approvedIndications":["EFO_0004274"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gout."}
{"id":"CHEMBL1199480","canonicalSmiles":"CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1","inchiKey":"ZVXNYZWXUADSRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTENIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octenidine"],"crossReferences":{"drugbank":["DB12624"]},"childChemblIds":["CHEMBL36342","CHEMBL2105832"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1200374","canonicalSmiles":"C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12","inchiKey":"BFYIZQONLCFLEV-DAELLWKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXEMESTANE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aromasin","Exemestane"],"synonyms":["Exemestane","FCE-24304","FCE24304","PNU-155971"],"crossReferences":{"DailyMed":["exemestane"],"PubChem":["144205052","170464628","26719821","49681613"],"Wikipedia":["Exemestane"],"drugbank":["DB00990"],"chEBI":["4953"]},"count":13,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000137869"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","MONDO_0004658","MONDO_0008170","MONDO_0007254","EFO_0000305","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0000304","EFO_0006861","MONDO_0011962","EFO_0000574","EFO_0000432","MONDO_0024880"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 approved and 8 investigational indications."}
{"id":"CHEMBL1200561","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O","inchiKey":"VJECBOKJABCYMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAZOSIN MESYLATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL707","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardozin xl","Cardura","Cardura xl","Cascor","Colixil xl","Doxadura","Doxazosin mesylate","Doxzogen xl","Larbex xl","Oxandosin xl","Raporsin xl","Slocinx xl"],"synonyms":["Doxazosin mesilate","Doxazosin mesylate","Doxazosin methanesulfonate","UK-33,274-27","UK-33274-27"],"crossReferences":{"DailyMed":["doxazosin%20mesylate"],"PubChem":["144204347","170465395","50106256","56422468","85231302","855527"],"chEBI":["4709"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0009094","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for hypertension."}
{"id":"CHEMBL1200836","canonicalSmiles":"Clc1ccc(CO/N=C(\\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O","inchiKey":"WVNOAGNOIPTWPT-NDUABGMUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXICONAZOLE NITRATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1262","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oceral","Oxiconazole nitrate","Oxistat"],"synonyms":["Oxiconazole nitrate","RO 13-8996","RO-13-8996","SGD 301-76","SGD-301-76","ST-813"],"crossReferences":{"DailyMed":["oxiconazole%20nitrate"],"PubChem":["144205020","170465226","26749046"],"chEBI":["7826"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and has 1 investigational indication."}
{"id":"CHEMBL1200951","canonicalSmiles":"CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"LRWSFOSWNAQHHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPHENAZINE ENANTHATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moditen enant","Prolixin","Prolixin enanthate"],"synonyms":["Fluphenazine","Fluphenazine enantate","Fluphenazine enanthate","Fluphenazine maleate","SQ 16,114","SQ 16144"],"crossReferences":{"chEBI":["5125"]},"count":6,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0000676","EFO_0005407","EFO_0005230","EFO_0000692","EFO_0005411"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for psychosis and has 5 investigational indications."}
{"id":"CHEMBL1201167","canonicalSmiles":"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O","inchiKey":"XCPXNPBILMXKNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARVEDILOL PHOSPHATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL723","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Coreg cr"],"synonyms":["Carvedilol phosphate","Carvedilol phosphate hemihydrate","Carvedilol phosphate hydrate","SK&F-105517-D","SKF 105517D","SKF-105517D"],"crossReferences":{"DailyMed":["carvedilol%20phosphate"]},"count":3,"approvedIndications":["EFO_0000612","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778"],"count":6},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0000373","EFO_0000612","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for hypertension and myocardial infarction and has 1 investigational indication."}
{"id":"CHEMBL1201724","drugType":"Unknown","blackBoxWarning":false,"name":"POVIDONE-IODINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betadine","Betadine vc kit","Betasept","Codella","E-z prep","E-z prep 220","E-z scrub","E-z scrub 201","E-z scrub 241","Povidone iodine"],"synonyms":["NSC-26245","Povidone iodine","Povidone-iodine"],"crossReferences":{"DailyMed":["povidone-iodine"],"DrugCentral":["4249"],"Wikipedia":["Povidone-iodine"]},"count":12,"approvedIndications":["EFO_1001888"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for eye infection and has 11 investigational indications."}
{"id":"CHEMBL1201863","canonicalSmiles":"Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2ccccc2[nH]1","inchiKey":"MJIHNNLFOKEZEW-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXLANSOPRAZOLE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexilant","Dexilant solutab","Kapidex"],"synonyms":["Dexlansoprazole","Lansoprazole r-form","T-168390","TAK-390"],"crossReferences":{"DailyMed":["dexlansoprazole"],"Wikipedia":["Dexlansoprazole"],"drugbank":["DB05351"]},"count":5,"approvedIndications":["EFO_0003948","HP_0004398","HP_0100633"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0000280","HP_0004398","EFO_1000961","HP_0100633","EFO_1001095"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1207949","canonicalSmiles":"O=P(O)(O)[C@@H](CCCc1cccc(Oc2ccccc2)c1)S(=O)(=O)O","inchiKey":"RCGCZPXSRLLKCK-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1207949","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07420"]},"childChemblIds":["CHEMBL462651"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213583","canonicalSmiles":"C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"SIGSPDASOTUPFS-XUDSTZEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTODENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gestodene","SH B 331","SH-B-331"],"crossReferences":{"PubChem":["144205785","170466131"],"Wikipedia":["Gestodene"],"drugbank":["DB06730"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1230193","canonicalSmiles":"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"SNMISNLUIRCRQE-SFSRYZOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230193","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02889"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231234","canonicalSmiles":"C[C@H](NC(=O)OCc1ccccc1)C(=O)O","inchiKey":"TYRGLVWXHJRKMT-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231234","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04634"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231267","canonicalSmiles":"OCCCCCCCCCCCCBr","inchiKey":"ASIDMJNTHJYVQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231267","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210020"],"drugbank":["DB02619"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232392","canonicalSmiles":"O[C@H](CS)[C@H](O)CS","inchiKey":"VHJLVAABSRFDPM-QWWZWVQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232392","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02184"],"chEBI":["42170"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235541","canonicalSmiles":"Sc1ccccn1","inchiKey":"WHMDPDGBKYUEMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-MERCAPTOPYRIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Mercaptopyridine"],"crossReferences":{"Wikipedia":["2-Mercaptopyridine"],"drugbank":["DB03329"],"chEBI":["45223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235825","canonicalSmiles":"CN(CC[C@H](N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"JISVTSUBJCPLSV-TWBCTODHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"aza-AdoMet","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["aza-AdoMet"],"crossReferences":{"drugbank":["DB03458"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236704","canonicalSmiles":"Nc1c[nH]c(=O)[nH]c1=O","inchiKey":"BISHACNKZIBDFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Aminouracil","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Aminouracil"],"crossReferences":{"drugbank":["DB03792"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1239","canonicalSmiles":"O=C(OCc1ccccc1)c1ccccc1","inchiKey":"SESFRYSPDFLNCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYL BENZOATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ascabiol","Benzyl benzoate","Mange Treatment","Scabanca","Vanzoate"],"synonyms":["Benzyl Benzoate","Benzyl benzoate","FEMA NO. 2138","NSC-8081"],"crossReferences":{"PubChem":["144204925","144208535","144213729","170465382","26748657","26753738","47193672"],"Wikipedia":["Benzyl_benzoate"],"drugbank":["DB00676"],"chEBI":["41237"]},"count":1,"approvedIndications":["EFO_0001067"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and is indicated for parasitic infection."}
{"id":"CHEMBL1256734","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(c3ccccc3)S(=O)(=O)O)C(=O)N2[C@H]1C(=O)O","inchiKey":"JETQIUPBHQNHNZ-OAYJICASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULBENICILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulbenicillin","Sulbenicillin sodium","Sulfobenzylpenicillin"],"crossReferences":{"chEBI":["9322"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL131854","canonicalSmiles":"O=C([C@@H](O)CO)N1CC=C(c2c(F)cc(N3C[C@H](COc4ccon4)OC3=O)cc2F)CC1","inchiKey":"HBUJYEUPIIJJOS-PBHICJAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POSIZOLID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD2563","Posizolid"],"crossReferences":{"drugbank":["DB04850"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1329455","canonicalSmiles":"CCOC(=O)[N-]c1c[n+](N2CCOCC2)no1","inchiKey":"XLFWDASMENKTKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOLSIDOMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corvasal","Corvaton","Corvaton mite","Corvaton ret"],"synonyms":["CAS 276","Molsidomine","Morsydomine"],"crossReferences":{"PubChem":["11111444","144203743","170465872","50104240","56423118","56463055","85231130","856013","90341588"],"drugbank":["DB09282"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL1331216","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@H](CO)c1ccccc1)C2","inchiKey":"RKUNBYITZUJHSG-FXUDXRNXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYOSCYAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hyoscyamine"],"crossReferences":{"PubChem":["50085944"],"drugbank":["DB00424"],"chEBI":["17486"]},"childChemblIds":["CHEMBL1697729","CHEMBL2106364","CHEMBL3989570"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1334097","canonicalSmiles":"C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O.O.[Na+]","inchiKey":"MUVVIYFKOVLQHL-RCVKHMDESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1334097","maximumClinicalTrialPhase":0,"parentId":"CHEMBL205596","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56322624"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL140000","canonicalSmiles":"CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1","inchiKey":"MXWDSZWTBOCWBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL140000","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["534548"],"drugbank":["DB02565"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1411","canonicalSmiles":"C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"NSMXQKNUPPXBRG-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LISOFYLLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Protec"],"synonyms":["CT 1501R","CT-1501R","Lisofylline"],"crossReferences":{"Wikipedia":["Lisofylline"],"drugbank":["DB12406"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1435","canonicalSmiles":"Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1","inchiKey":"MLYYVTUWGNIJIB-BXKDBHETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAZOLIN","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefazolin","Cephazolin","J01DB04","SK&F-41558"],"crossReferences":{"PubChem":["144205244","170465254","29215418","47193754","90340701"],"Wikipedia":["Cefazolin"],"drugbank":["DB01327"],"chEBI":["474053"]},"childChemblIds":["CHEMBL1200523"],"count":13,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for bacterial disease and has 12 investigational indications."}
{"id":"CHEMBL1450","canonicalSmiles":"O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21","inchiKey":"KUCQYCKVKVOKAY-CTYIDZIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATOVAQUONE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atovaquone","Mepron","Wellvone"],"synonyms":["566C","566C80","Atovaquone","Mepron"],"crossReferences":{"DailyMed":["atovaquone"],"PubChem":["144204265","170464681"],"Wikipedia":["Atovaquone"],"drugbank":["DB01117"],"chEBI":["575568"]},"count":6,"approvedIndications":["EFO_0007448","EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for malaria and pneumocystosis and has 4 investigational indications."}
{"id":"CHEMBL1525287","canonicalSmiles":"COP(=S)(OC)Oc1ccc(S(=O)(=O)N(C)C)cc1","inchiKey":"JISACBWYRJHSMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1525287","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205499","144212224","170466840","29216324"],"drugbank":["DB11408"],"chEBI":["38677"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1577","canonicalSmiles":"CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O","inchiKey":"CESYKOGBSMNBPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYCLOTHIAZIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquatensen","Enduron","Methyclothiazide"],"synonyms":["Methyclothiazide"],"crossReferences":{"PubChem":["144206003","170465243","92764517"],"Wikipedia":["Methyclothiazide"],"drugbank":["DB00232"],"chEBI":["6847"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1652611","canonicalSmiles":"CC[C@@H]1CCN[C@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)C1","inchiKey":"HBJOXQRURQPDEX-MHXMMLMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRLIMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirlimycin"],"crossReferences":{"Wikipedia":["Pirlimycin"],"drugbank":["DB11537"]},"childChemblIds":["CHEMBL3989899"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697","canonicalSmiles":"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1.Cl","inchiKey":"HDRXZJPWHTXQRI-BHDTVMLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILTIAZEM HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL23","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adizem-60","Adizem-sr","Adizem-xl","Angiozem 60","Angiozem cr 120","Angiozem cr 90","Angitil sr 120","Angitil sr 180","Angitil sr 90","Angitil xl 240","Angitil xl 300","Anoheal","Bi-carzem sr","Bi-carzem xl","Britiazim","Calazem","Calcicard","Calcicard cr","Cardizem","Cardizem cd","Cardizem la","Cardizem sr","Cartia xt","Dilacor","Dilacor xr","Dilcardia sr","Dilcardia xl","Dilt-cd","Diltiazem hydrochloride","Diltzac","Dilzem sr 120","Dilzem sr 60","Dilzem sr 90","Dilzem xl 120","Dilzem xl 180","Dilzem xl 240","Disogram sr","Horizem sr 120","Horizem sr 60","Horizem sr 90","Kentiazem","Kenzem sr","Optil","Optil sr 120","Optil sr 180","Optil sr 90","Optil xl 240","Optil xl 300","Retalzem 60","Slozem","Slozem 120","Slozem 180","Slozem 240","Taztia xt","Tiamex","Tiazac","Tildiem","Tildiem la 200","Tildiem la 300","Tildiem ret 120","Tildiem ret 90","Uard 120xl","Uard 180xl","Uard 240xl","Uard 300xl","Viazem xl","Zemret 180 xl","Zemret 240 xl","Zemret 300 xl","Zemtard 120 xl","Zemtard 180 xl","Zemtard 240 xl","Zemtard 300 xl","Zildil sr"],"synonyms":["CRD-401","Diltiazem hydrochloride","RG 83606","RG-83606"],"crossReferences":{"DailyMed":["diltiazem%20hydrochloride"],"PubChem":["50106088","56422509","855699"],"chEBI":["645509"]},"count":8,"approvedIndications":["EFO_0003913"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["HP_0012390","EFO_0000275","EFO_0003144","EFO_0000764","EFO_0000701","HP_0002019","EFO_0000537","EFO_0003913"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for angina pectoris and has 7 investigational indications."}
{"id":"CHEMBL171281","canonicalSmiles":"N[C@H](CS)C(=O)O","inchiKey":"XUJNEKJLAYXESH-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL171281","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756687"],"drugbank":["DB03201"],"chEBI":["16375"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743046","drugType":"Antibody","blackBoxWarning":false,"name":"NARNATUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC RON-8","IMC-RON-8","IMC-RON8","Narnatumab","RON-8","RON8"],"count":1,"linkedTargets":{"rows":["ENSG00000164078"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743056","drugType":"Antibody","blackBoxWarning":false,"name":"PATECLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLTA-3698A","MLTA3698A","PRO-283698","PRO283698","Pateclizumab","RG-7416","RG7415"],"count":1,"linkedTargets":{"rows":["ENSG00000226979"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL175083","canonicalSmiles":"Nc1nc(O)c(N)c(O)n1","inchiKey":"HWSJQFCTYLBBOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175083","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1796998","canonicalSmiles":"FS(F)(F)(F)(F)F","inchiKey":"SFZCNBIFKDRMGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFUR HEXAFLUORIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sonovue (for the microbubble formulation)"],"synonyms":["BRI","Sulfur hexafluoride","Sulfur hexafluoride, phospholipid microspheres"],"crossReferences":{"drugbank":["DB11104"],"chEBI":["30496"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1808698","canonicalSmiles":"O=C[C@H]([18F])[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"AOYNUTHNTBLRMT-MXWOLSILSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1808698","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1908940","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09502"],"chEBI":["49136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1813067","canonicalSmiles":"C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1.Cl","inchiKey":"WJUJICMNSMPLLG-PFEQFJNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRDABISANT HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1829335","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-26401","CEP-26401 hydrochloride","Irdabisant hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL187835","canonicalSmiles":"CC(C)[C@@H](NC(N)=O)C(=O)O","inchiKey":"JDXMIYHOSFNZKO-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL187835","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01847"],"chEBI":["41469"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1879513","canonicalSmiles":"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O.O","inchiKey":"DTSOZYYWEZJFSS-XTHCGPPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1879513","maximumClinicalTrialPhase":0,"parentId":"CHEMBL177","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576734"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190677","canonicalSmiles":"O=C(c1ccccc1)C(O)c1ccccc1","inchiKey":"ISAOCJYIOMOJEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzoin","Benzoin tincture"],"crossReferences":{"PubChem":["144204677","144209086","144213107","170465507","17390021","26752995","56463440"],"Wikipedia":["Benzoin"],"drugbank":["DB14020"],"chEBI":["17682"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1908845","canonicalSmiles":"CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O","inchiKey":"AJBMORBNKXNZSF-SXFYKSCTSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"IDRAPARINUX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1908371"],"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003827","EFO_0003907"],"count":3},"description":"Oligosaccharide drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL192008","canonicalSmiles":"Cc1ccc(O)cc1C","inchiKey":"YCOXTKKNXUZSKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4--Xylenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4--Xylenol","3,4-Dimethyl-Phenol","3,4-Dimethylphenol"],"crossReferences":{"PubChem":["144208721","144210505","17389286"],"drugbank":["DB04052"],"chEBI":["39839"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL194322","canonicalSmiles":"CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12","inchiKey":"OVCXRBARSPBVMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-808844","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-808844"],"crossReferences":{"drugbank":["DB04797"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL202431","canonicalSmiles":"O=C(Nc1c(F)cc(-c2cccc(OC(F)(F)F)c2)cc1F)c1ccsc1C(=O)O","inchiKey":"CGNHUSCKOHDSMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202431","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL207701","canonicalSmiles":"CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1N1CCNCC1","inchiKey":"SORAKBHHTGVZCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207701","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06958"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103745","canonicalSmiles":"N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2.O","inchiKey":"AFNTWHMDBNQQPX-NHKADLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAXAGLIPTIN","maximumClinicalTrialPhase":4,"parentId":"CHEMBL385517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Onglyza"],"synonyms":["BMS-477118","BMS-477118-11","Saxagliptin","Saxagliptin hydrate","Saxagliptin monohydrate"],"crossReferences":{"chEBI":["71271"]},"count":5,"approvedIndications":["EFO_0000400"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 4 investigational indications."}
{"id":"CHEMBL2104094","canonicalSmiles":"OC(c1ccc(Cl)cc1)c1cc2ccccc2o1","inchiKey":"KBFBRIPYVVGWRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORIDAROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cloridarol"],"crossReferences":{"drugbank":["DB13291"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104255","canonicalSmiles":"CCCCCCCCCCCC[N+](CCO)(CCO)Cc1ccccc1.[Cl-]","inchiKey":"UUSQFLGKGQEVCM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOXONIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110609","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoxonium chloride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104926","canonicalSmiles":"N#CCCN1C(=O)C(O)N=C(c2ccccc2F)c2cc(Cl)ccc21","inchiKey":"XAXMYHMKTCNRRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINOLAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinolazepam"],"crossReferences":{"drugbank":["DB01594"],"chEBI":["59514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105689","canonicalSmiles":"N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1","inchiKey":"YTAOBBFIOAEMLL-REQDGWNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LULICONAZOLE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Luzu"],"synonyms":["Luliconazole","NND-502","PR-2699"],"crossReferences":{"DailyMed":["luliconazole"],"PubChem":["144206495","144206527","144206804"],"drugbank":["DB08933"],"chEBI":["34825"]},"count":2,"approvedIndications":["EFO_0007510","EFO_0007512"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for tinea and tinea pedis."}
{"id":"CHEMBL2106667","canonicalSmiles":"COS(=O)(=O)[O-].COc1cc(N)cn[n+]1-c1ccccc1","inchiKey":"ZEASXVYVFFXULL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMEZINIUM METILSULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110922","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amezinium metilsulfate"],"crossReferences":{"drugbank":["DB13330"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106988","canonicalSmiles":"CC(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)Cc3ccccc3)[C@H]2SC1(C)C","inchiKey":"NLOOMWLTUVBWAW-HLLBOEOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENAMECILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Havapen"],"synonyms":["Penamecillin","WY-20,788"],"crossReferences":{"drugbank":["DB13739"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL2107067","canonicalSmiles":"CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"UDSFVOAUHKGBEK-CNQKSJKFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TESTOSTERONE UNDECANOATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Andriol","Aveed","Jatenzo","Nebido","Restandol","Restandol testocap","Undestor"],"synonyms":["MK-3033","ORG 538","ORG-538","TSX-011","Testosterone undecanoate"],"crossReferences":{"DailyMed":["testosterone%20undecanoate"],"drugbank":["DB13946"]},"count":7,"approvedIndications":["MONDO_0002146","MONDO_0018555"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["GO_0007568","EFO_0009686","MONDO_0002146","EFO_0004714","EFO_0008572","HP_0003549","EFO_0003144","EFO_0004234","EFO_0001645","EFO_0000681","EFO_1001919","MONDO_0018555","EFO_0003913"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for hypogonadism and hypogonadotropic hypogonadism and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107239","canonicalSmiles":"CC(=O)Nc1c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c1I","inchiKey":"OLAOYPRJVHUHCF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOXITALAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG 58107","Ioxitalamic acid"],"crossReferences":{"drugbank":["DB13444"],"chEBI":["83517"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107309","canonicalSmiles":"Cc1sc[n+](CC(=O)c2ccccc2)c1C.[Cl-]","inchiKey":"MKOMESMZHZNBIZ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ALAGEBRIUM CHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111081","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALT-711","Alagebrium chloride"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107317","canonicalSmiles":"CS(=O)(=O)O.O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1","inchiKey":"ONWKHSGOYGLGPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFEPRUNOX MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL218166","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifeprunox mesylate","DU127090"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107872","drugType":"Protein","blackBoxWarning":false,"name":"DELCASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-875944","Delcasertib","KAI-9803","Kai-9803"],"count":1,"linkedTargets":{"rows":["ENSG00000163932"],"count":1},"linkedDiseases":{"rows":["EFO_0000612"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107914","drugType":"Unknown","blackBoxWarning":false,"name":"OPIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDS-NO-001","Opium","Papaver somniferum resin"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2108172","drugType":"Unknown","blackBoxWarning":false,"name":"ACACIA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acacia","Acacia senegal","Acacia senegal gum","E-414-","FEMA NO. 2001","Gum arabic","INS NO.414","INS-414"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108391","drugType":"Unknown","blackBoxWarning":false,"name":"HONEY","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Honey"],"count":7,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108407","drugType":"Antibody","blackBoxWarning":false,"name":"FARALIMOMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Faralimomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109464","drugType":"Antibody","blackBoxWarning":false,"name":"CNTO-5825","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNTO-5825","Cnto-5825"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109506","drugType":"Antibody","blackBoxWarning":false,"name":"HU3S193","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HU3S193","Hu3s193"],"count":6,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109680","drugType":"Antibody","blackBoxWarning":false,"name":"IDEC-159 90Y","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-159","Idec-159 (90y)","Idec-159 90y"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2135887","canonicalSmiles":"CC=Cc1ccc(O)c(OC)c1","inchiKey":"BJIOGJUNALELMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIS/TRANS-ISOEUGENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204689","144209631","144210623","170465654"],"drugbank":["DB14188"],"chEBI":["18224"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL215205","canonicalSmiles":"Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1","inchiKey":"AYZRKFOEZQBUEA-OUKQBFOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL215205","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07731"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220396","canonicalSmiles":"COc1cncc(-c2cccc(CNc3cccnc3N)c2)c1","inchiKey":"PGAWZMRRCVSRIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220396","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07303"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL224436","canonicalSmiles":"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O","inchiKey":"XJSFLOJWULLJQS-NGVXBBESSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JOSAMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EN-141","Josamycin","Josamycin propionate"],"crossReferences":{"Wikipedia":["Josamycin"],"drugbank":["DB01321"],"chEBI":["31739"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2364617","canonicalSmiles":"CC(=O)O.CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O","inchiKey":"WVDSKQXKCDZXLH-OHIDFYLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACIMORELIN ACETATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL278623","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Macrilen"],"synonyms":["ARD 07","D-87575","EP 1572","Macimorelin acetate"],"crossReferences":{"DailyMed":["macimorelin%20acetate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017."}
{"id":"CHEMBL24683","canonicalSmiles":"CCO[C@H](Cc1ccc(OCCN2c3ccccc3Oc3ccccc32)cc1)C(=O)O","inchiKey":"WMUIIGVAWPWQAW-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL24683","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06533"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24722","canonicalSmiles":"CCCCCCCCCCCCO","inchiKey":"LQZZUXJYWNFBMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DODECANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Dodecanol","Dodecan-1-ol"],"crossReferences":{"PubChem":["144209322","144210440"],"Wikipedia":["Dodecanol"],"drugbank":["DB06894"],"chEBI":["28878"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24811","canonicalSmiles":"O=Cc1ccccc1OP(=O)(O)OCC1CCCCC1","inchiKey":"YBEVTZVQKMYQPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Phosphoric Acid Cyclohexylmethyl Ester 2-Formyl-Phenyl Ester","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphoric Acid Cyclohexylmethyl Ester 2-Formyl-Phenyl Ester"],"crossReferences":{"drugbank":["DB03114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL249847","canonicalSmiles":"CNC(=O)[C@H](Cc1ccccc1)NC(=O)Nc1n[nH]c(=S)s1","inchiKey":"RKWXKADYTDWZIJ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PNU-107859","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-107859"],"crossReferences":{"drugbank":["DB07390"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL250270","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"ZDXUKAKRHYTAKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LERCANIDIPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lercanidipine"],"crossReferences":{"PubChem":["50112745","90340703"],"Wikipedia":["Lercanidipine"],"drugbank":["DB00528"]},"childChemblIds":["CHEMBL2106419"],"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_1002032","EFO_0000319","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL250892","canonicalSmiles":"N[C@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O","inchiKey":"SGDBTWWWUNNDEQ-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-MELPHALAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(r)-melphalan","melphalan"],"crossReferences":{"PubChem":["11111435"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL253976","canonicalSmiles":"C[C@H](Oc1cccc2nc(N)nc(N)c12)c1cccc(Cl)c1","inchiKey":"IDHINEMSCUFEIP-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253976","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07644"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255590","canonicalSmiles":"NCc1ccc2c(c1)C1(CCN(C(=O)c3ccc(C#Cc4ccccc4)o3)CC1)CO2","inchiKey":"YKTUSHSSKIWDRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-27390467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-27390467"],"crossReferences":{"drugbank":["DB06962"]},"childChemblIds":["CHEMBL402416"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL263143","canonicalSmiles":"O=C1NC(=O)c2ccc(Br)cc2/C1=C/Nc1ccc(CN2CCCC2)cc1","inchiKey":"JFEKAVPMVOLVTH-UNOMPAQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL263143","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07156"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL264241","canonicalSmiles":"CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1","inchiKey":"JHVAMHSQVVQIOT-MFAJLEFUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANIDULAFUNGIN","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ecalta","Eraxis"],"synonyms":["Anidulafungin","D70013","LY-303366","LY303366","VER-002","VER002"],"crossReferences":{"DailyMed":["anidulafungin"],"drugbank":["DB00362"],"chEBI":["55346"]},"childChemblIds":["CHEMBL1275711"],"count":11,"approvedIndications":["EFO_0008588","EFO_1001282","MONDO_0002026"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 8 investigational indications."}
{"id":"CHEMBL279597","canonicalSmiles":"C[C@H](N)C(=O)O","inchiKey":"QNAYBMKLOCPYGJ-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-ALANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113404"],"drugbank":["DB00160"],"chEBI":["16977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL287386","canonicalSmiles":"C[C@H](N)Cc1ccccc1.Cl","inchiKey":"SEVKYLYIYIKRSW-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL287386","maximumClinicalTrialPhase":0,"parentId":"CHEMBL612","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29641","canonicalSmiles":"COc1cc2ncnc(Nc3cccc(SC)c3)c2cc1OC","inchiKey":"FUSDVOSGGMBSMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL29641","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02984"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL300982","canonicalSmiles":"CC1(C)Cc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(CC(=O)O)n2C1","inchiKey":"UAWXGRJVZSAUSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LICOFELONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Licofelone","ML-3000"],"crossReferences":{"PubChem":["137275875"],"drugbank":["DB04725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039530","canonicalSmiles":"O=c1ccc2c([C@@H](O)CNCCCCCCOCC(F)(F)c3ccccc3)ccc(O)c2[nH]1","inchiKey":"SFYAXIFVXBKRPK-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABEDITEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abediterol","LAS-100977","LAS100977"],"crossReferences":{"drugbank":["DB12100"]},"childChemblIds":["CHEMBL3039510"],"count":2,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL309339","canonicalSmiles":"O=C(NO)c1ccccc1O","inchiKey":"HBROZNQEVUILML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALICYLHYDROXAMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,N-Dihydroxy-Benzamide","Salicylhydroxamic Acid","Salicylic Hydroxamic Acid"],"crossReferences":{"PubChem":["56422153","855524"],"Wikipedia":["Salicylhydroxamic_acid"],"drugbank":["DB03819"],"chEBI":["45615"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL31","canonicalSmiles":"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"XUBOMFCQGDBHNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GATIFLOXACIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Gastrotoxicity"],"year":2006},"tradeNames":["Gatifloxacin","Tequin","Zymar","Zymaxid"],"synonyms":["AM-1155","BMS-206584-01","BMS-20658401","Gatifloxacin","Gatifloxacin hydrate","Gatifloxacin sesquihydrate","PD-135432"],"crossReferences":{"DailyMed":["gatifloxacin"],"PubChem":["103905240","104171401","124888832","144204535","170465592","26748958","861394"],"Wikipedia":["Gatifloxacin"],"drugbank":["DB01044"],"chEBI":["5280"]},"childChemblIds":["CHEMBL3764608","CHEMBL1974188"],"count":7,"approvedIndications":["EFO_1000829","EFO_0000771","EFO_0000544","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 4 approved and 3 investigational indications. It was withdrawn in United States  in 2006 due to Gastrotoxicity."}
{"id":"CHEMBL3120793","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@](C)(O)[C@@H]1OC(=O)C(C)C)Oc1ccccc1","inchiKey":"YAAQYJCOIFNMKX-RSTNYOGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS-6620","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-6620","Gs-6620"],"crossReferences":{"drugbank":["DB15222"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL313136","canonicalSmiles":"CC1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1","inchiKey":"WHXMKTBCFHIYNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMENDAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simendan"],"crossReferences":{"Wikipedia":["Levosimendan"],"drugbank":["DB12286"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137355","drugType":"Small molecule","blackBoxWarning":false,"name":"VEPOLOXAMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MST-188","Vepoloxamer"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL316308","canonicalSmiles":"CC(C)(C)C(=O)Nc1cccnc1C(=O)Nc1nccs1","inchiKey":"CAVCWRXFMNCBCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL316308","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07903"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182444","canonicalSmiles":"O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1","inchiKey":"LCVIRAZGMYMNNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-5108","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK 5108","MK5108","Mk-5108","VX-689"],"crossReferences":{"PubChem":["174006374"]},"count":1,"linkedTargets":{"rows":["ENSG00000087586"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3183451","canonicalSmiles":"CS(=O)(=O)O.C[C@H]1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21.O","inchiKey":"IGTHEWGRXUAFKF-NVJADKKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GARENOXACIN MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL215303","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-284756-01","Garenoxacin mesylate","T-3811ME"],"crossReferences":{"PubChem":["144206547","170465937"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183486","canonicalSmiles":"Cl.FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1","inchiKey":"WVHBEIJGAINUBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183486","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1512580","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206120","170465603"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188267","canonicalSmiles":"CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F","inchiKey":"LIOLIMKSCNQPLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPMATINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Capmatinib","INC-280","INC280","INCB-28060","INCB-28060 FREE BASE","Incb-28060","NVP-INC280","NVP-INC280-NX","NYP-INC280-NX"],"crossReferences":{"DailyMed":["capmatinib%20hydrochloride"],"PubChem":["174006562"],"drugbank":["DB11791"]},"childChemblIds":["CHEMBL3989937"],"count":11,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","MONDO_0008903","EFO_0001421","EFO_0000182","MONDO_0007254","EFO_0000389","MONDO_0002367","EFO_1001968","EFO_0003060","EFO_0000519"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 11 investigational indications."}
{"id":"CHEMBL3230485","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1.[Li+]","inchiKey":"VLJXYASGGIMGRO-CFOLLTDRSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3230485","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1146","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL324942","canonicalSmiles":"O=C(Nc1cc(C2CC2)n[nH]1)c1ccccc1","inchiKey":"LUCORKWTQSQFFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL324942","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02647"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3273169","canonicalSmiles":"Br.NC[C@H](O)c1ccc(O)c(O)c1","inchiKey":"PLFTVNOQDBGVCK-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3273169","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1437","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL334533","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@H]1CC=C(CO)C[C@H]21","inchiKey":"SSQJFGMEZBFMNV-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXANABINOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexanabinol","HU-210","HU-211","PA-50211","PRS-211007","PRS-211007-000","Sinnabidol"],"crossReferences":{"drugbank":["DB06444"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL335954","canonicalSmiles":"O=C(N[C@@H](Cc1ccccc1)C(=O)N1CC(C(=O)O)C1)c1cc2cc(Cl)ccc2[nH]1","inchiKey":"RONLONYAIBUEKT-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-403700","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-403700"],"crossReferences":{"drugbank":["DB03744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527302","canonicalSmiles":"C[14c]1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1","inchiKey":"ZJXIUGNEAIHSBI-LWZJPYGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3527302","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1272307","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544537","canonicalSmiles":"Oc1ccc(C(c2ccc(O)cc2)c2ccccn2)cc1","inchiKey":"LJROKJGQSPMTKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROXYDIPHENYL-PYRIDYL METHANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydroxydiphenyl-pyridyl methane"],"crossReferences":{"drugbank":["DB14232"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545008","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-260301","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR260301","Sar-260301"],"count":1,"linkedTargets":{"rows":["ENSG00000051382"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545081","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7304","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CKI-27","Rg-7304","Ro-5126766"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545253","canonicalSmiles":"[18F]c1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1","inchiKey":"GETAAWDSFUCLBS-SJPDSGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORTAUCIPIR F 18","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3546271","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tauvid"],"synonyms":["(F-18)T807","18F-AV-1451","AV-1451 F-18","Flortaucipir (18f)","Flortaucipir f 18","Flortaucipir f-18","LY-3191748","LY3191748","T-807 F-18","T807 F-18","[F-18]T807"],"crossReferences":{"DailyMed":["flortaucipir%20f-18"],"drugbank":["DB14914"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL3545257","canonicalSmiles":"CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O.O=S(=O)(O)c1ccccc1","inchiKey":"OKJXJRVWXYRSAN-TXULWXBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIROGABALIN BESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545125","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-5565","Ds-5565","Mirogabalin","Mirogabalin besylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545409","drugType":"Small molecule","blackBoxWarning":false,"name":"BVT.115959","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bvt.115959"],"count":1,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0005762"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707279","drugType":"Unknown","blackBoxWarning":false,"name":"ADAGLOXAD SIMOLENIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adagloxad simolenin","OBI-822"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707312","canonicalSmiles":"COC(=O)c1cccc(CCN(C)CCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)c1","inchiKey":"VAZNEHLGJGSQEL-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRIPAMIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-MSP-2017","Etripamil","MS)-MSP-2017","MSP-2017"],"crossReferences":{"drugbank":["DB12605"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL3707316","drugType":"Small molecule","blackBoxWarning":false,"name":"ND0801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nd0801"],"count":1,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0003888"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3716057","canonicalSmiles":"COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O","inchiKey":"HLWURFKMDLAKOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEFAPIXANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF-219","Af-219","Gefapixant","R-1646","R1646","RG-1646","RG1646","RO-4926219","RO4926219"],"crossReferences":{"drugbank":["DB15097"]},"childChemblIds":["CHEMBL4594278"],"count":7,"linkedTargets":{"rows":["ENSG00000109991"],"count":1},"linkedDiseases":{"rows":["HP_0000083","HP_0012735","EFO_0000270","EFO_0000768","EFO_0008507","EFO_0004616","EFO_0003918"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3785780","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12.[Na+]","inchiKey":"WPAHYZYZUZTKDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3785780","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1542","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL389051","canonicalSmiles":"C#CCN(Cc1ccc2[nH]c(N)nc(=O)c2c1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"LTKHPMDRMUCUEB-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CB-3717","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-3717","TCMDC-131823"],"crossReferences":{"drugbank":["DB03541"],"chEBI":["3258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL390674","canonicalSmiles":"Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2)n1","inchiKey":"QQBNDYARFVOEGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL390674","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3911801","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1","inchiKey":"HDYUXDNMHBQKAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3911801","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545076","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3950712","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NCC1CCN(CCCn2ccnn2)CC1","inchiKey":"AULLTYAISZREAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DA-6886","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Da-6886"],"crossReferences":{"drugbank":["DB12853"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL39677","canonicalSmiles":"c1ccc2nc3ccccc3cc2c1","inchiKey":"DZBUGLKDJFMEHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACRIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acridine","NSC-3408"],"crossReferences":{"PubChem":["124892352","26755289"],"Wikipedia":["Acridine"],"chEBI":["36420"]},"childChemblIds":["CHEMBL4103461"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3971095","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2cc(F)c3c(c2)O[C@@H](c2cnc(C4CC4)s2)n2c-3cc3cc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)ccc32)[nH]1)C(C)C","inchiKey":"AXWDHVUJXNOWCC-RAEGKSCOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3971095","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL405355","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1","inchiKey":"SVJMLYUFVDMUHP-XIFFEERXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIGULDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-niguldipine","Niguldipine"],"crossReferences":{"PubChem":["11113931","11113932"],"drugbank":["DB09239"]},"childChemblIds":["CHEMBL2303676"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4065122","canonicalSmiles":"C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1","inchiKey":"WNEODWDFDXWOLU-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENEBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenebrutinib","G-02599853","G02599853","GDC-0853","Gdc-0853","RG-7845","RG7845","RO-7010939","RO7010939"],"crossReferences":{"drugbank":["DB14785"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4094894","canonicalSmiles":"CC(C)c1cccc([C@H](C)C2CC2)c1O","inchiKey":"BMEARIQHWSVDBS-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HSK-3486","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HSK-3486","HSK-3486, (R)-","HSK3486","Hsk-3486","Hsk3486"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL415087","canonicalSmiles":"Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1","inchiKey":"FLNXBVJLPJNOSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPERASTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cloperastine","Cloperastine fendizoate","Cloperastine hydrochloride","HT-11"],"crossReferences":{"Wikipedia":["Cloperastine"],"drugbank":["DB09002"]},"childChemblIds":["CHEMBL1492516"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL427409","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"SYJXFKPQNSDJLI-HKEUSBCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neamine"],"crossReferences":{"drugbank":["DB04808"],"chEBI":["7489"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297269","canonicalSmiles":"CN1C(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C(c2ccccc2)c2ccccc21","inchiKey":"AYOUDDAETNMCBW-GSHUGGBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-906024","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-101","AL101","Al-101","Al101","BMS-906024","Bms 906024","Bms-906024"],"crossReferences":{"drugbank":["DB12006"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL429736","canonicalSmiles":"CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1","inchiKey":"PLVGDGRBPMVYPB-FDUHJNRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETOSIBAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-221149","GSK-221149A","GSK221149","GSK221149A","Retosiban"],"crossReferences":{"drugbank":["DB11818"]},"count":1,"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0003917"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297419","canonicalSmiles":"CCCCCCCC(C(=O)c1ccccc1)N1CCCC1","inchiKey":"RYJXAZXFWIWTOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":".ALPHA.-PYRROLIDINONONANOPHENONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-pyrrolidinononanophenone","Pv-10"],"crossReferences":{"drugbank":["DB05531"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297628","canonicalSmiles":"NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)C(c1ccccc1)c1ccccc1","inchiKey":"GGAKLYWEFZCVIT-TVEKFXMRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RUXOTEMITIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ltx 315","Ltx-315","Ruxotemitide"],"crossReferences":{"drugbank":["DB12748"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297837","drugType":"Antibody","blackBoxWarning":false,"name":"TALACOTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CSL-362","CSL362","Csl362","JNJ-56022473","Jnj-56022473","Talacotuzumab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297967","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-3050002","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-3050002","GSK3050002","Gsk-3050002","Gsk3050002","HGS-1035","HGS1035","KANAB071"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298091","drugType":"Antibody","blackBoxWarning":false,"name":"CIBISATAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cibisatamab","RG-7802","RG7802","RO 6958688","RO-6958688","RO6958688","Ro 6958688","Ro6958688"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298096","drugType":"Unknown","blackBoxWarning":false,"name":"MIK-665","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mik-665","S 64315","S64315"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298097","drugType":"Antibody","blackBoxWarning":false,"name":"ROMILKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Romilkimab","SAR-156597","SAR156597","Sar156597"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL432600","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@@H](C)OCCCC(O)(CC)CC)CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"KLZOTDOJMRMLDX-YBBVPDDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEXACALCITOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lexacalcitol"],"crossReferences":{"drugbank":["DB03451"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL437526","canonicalSmiles":"CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN2C(=O)CC[C@H](NC(=O)c3nccc4ccccc34)C(=O)N12","inchiKey":"CXAGHAZMQSCAKJ-WAHHBDPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALNACASAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HMR3480","HMR3480/VX-740","Pralnacasan","VX-740"],"crossReferences":{"drugbank":["DB04875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL438605","canonicalSmiles":"C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O","inchiKey":"PPUDLEUZKVJXSZ-VPCXQMTMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-C-Mecytosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-C-Mecytosine","2'-C-Methylcytidine","2'C-Me-C"],"crossReferences":{"drugbank":["DB13921"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4467191","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2.Cl","inchiKey":"USUHXXKCHSBMOS-XPSHAMGMSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4467191","maximumClinicalTrialPhase":0,"parentId":"CHEMBL659","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594322","drugType":"Protein","blackBoxWarning":false,"name":"EFTOZANERMIN ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-621","Abbv 621","Abbv-621","Eftozanermin alfa"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594426","canonicalSmiles":"N#Cc1ccc(COc2ccc(C#Cc3ccc(C(F)(F)[C@](O)(Cn4cnnn4)c4ccc(F)cc4F)nc3)cc2)cc1","inchiKey":"UDGASIIGNCBLSI-PMERELPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VT-1598","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VT-1598","Vt-1598"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594538","drugType":"Unknown","blackBoxWarning":false,"name":"DV-281","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DV-281","DV281","Dv-281","Dv281"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594551","drugType":"Unknown","blackBoxWarning":false,"name":"HUMAN RECOMBINANT BONE MORPHOGENETIC PROTEIN 4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hrbmp4","Human recombinant bone morphogenetic protein 4"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594553","drugType":"Unknown","blackBoxWarning":false,"name":"IBI-188","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IBI-188","IBI188","Ibi-188","Ibi188"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL468900","canonicalSmiles":"O=C(NCc1cccnc1)c1cc(C(=O)NCc2cccnc2)ncn1","inchiKey":"NHPBWKYFMTXWAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL468900","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04761"],"chEBI":["593538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL472","canonicalSmiles":"COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1","inchiKey":"ZNNLBTZKUZBEKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYBURIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calabren","Daonil","Diabeta","Diabetamide 2.5","Diabetamide 5","Euglucon","Gliken","Glyburide","Glyburide (micronized)","Glynase","Glynase Prestab","Lederglib","Libanil","Malix","Micronase","Semi-daonil"],"synonyms":["Glibenclamide","Glyburide","HB 419","HB-419","U-26,45","U-26,452","U-26452"],"crossReferences":{"DailyMed":["glyburide"],"PubChem":["11111219","11112597","11113353","144203709","144211075","170464964","26747031","26747032","26751550","50100249","50104148","50104149","50104150","50126365","56422139","85231061","855894"],"TG-GATEs":["42"],"Wikipedia":["Glibenclamide"],"drugbank":["DB01016"],"chEBI":["5441"]},"count":7,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0004593","EFO_0000713","HP_0002140","EFO_0001359","EFO_0000712","EFO_1001919","MONDO_0043510","EFO_0001360","EFO_0000400","EFO_0003913"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for type ii diabetes mellitus and diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL489156","canonicalSmiles":"COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1","inchiKey":"JBJYTZXCZDNOJW-JLHYYAGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489156","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111311","50106919","50106920","85231087","90340751"],"drugbank":["DB03083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL491473","canonicalSmiles":"COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1","inchiKey":"XXJWYDDUDKYVKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEDIRANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Recentin"],"synonyms":["AZD-2171","AZD2171","Azd-2171","Cediranib","ZD-2171"],"crossReferences":{"PubChem":["103905340","137275941"],"drugbank":["DB04849"]},"childChemblIds":["CHEMBL2103798"],"count":28,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721"],"count":6},"linkedDiseases":{"rows":["EFO_0003891","EFO_1000403","EFO_0000681","EFO_1001465","EFO_1000657","MONDO_0007254","MONDO_0002087","EFO_0000305","EFO_1001951","EFO_0000565","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_0000588","MONDO_0002974","EFO_0009709","EFO_0000389","EFO_0000770","EFO_0000182","MONDO_0008903","EFO_0000673","EFO_0002617","EFO_0000616","EFO_0003893","MONDO_0008170","EFO_0000349","EFO_0000222","MONDO_0023619","EFO_0003060","MONDO_0008315","MONDO_0003865","EFO_0000311","EFO_0007143","EFO_0006861","EFO_0000095","EFO_0002892","MONDO_0011962","EFO_0000702","EFO_0000519"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 28 investigational indications."}
{"id":"CHEMBL498","canonicalSmiles":"CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1","inchiKey":"RKWGIWYCVPQPMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROPAMIDE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorpropamide","Diabemide","Diabinese","Glucamide","Glymese","Melitase"],"synonyms":["Chlorpropamide"],"crossReferences":{"PubChem":["11110918","11110919","144203653","144208589","144213106","170464898","17389965","50103916","56423142","855559"],"TG-GATEs":["80"],"Wikipedia":["Chlorpropamide"],"drugbank":["DB00672"],"chEBI":["3650"]},"count":2,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and is indicated for type ii diabetes mellitus and diabetes mellitus."}
{"id":"CHEMBL501637","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C","inchiKey":"YURJSTAIMNSZAE-HHNZYBFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RG1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ginsenoside Rg1"],"crossReferences":{"Wikipedia":["Ginsenoside"],"drugbank":["DB06750"],"chEBI":["67987"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL525194","canonicalSmiles":"c1cnn2ncc(-c3ccnc(NC4CC4)n3)c2c1","inchiKey":"CAGHIASAHLPQMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL525194","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07164"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL531472","canonicalSmiles":"CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LJOQGZACKSYWCH-LHHVKLHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL531472","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15300"]},"childChemblIds":["CHEMBL533007"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539697","canonicalSmiles":"CCCCCCOC(=O)/N=C(\\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1","inchiKey":"KSGXQBZTULBEEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DABIGATRAN ETEXILATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pradaxa"],"synonyms":["BIBR 1048","BIBR 1048 BS RS1","BIBR-1048","BIBR-1048-BS-RS1","Dabigatran etexilate","Dabigatran etexilate methanesulfonate"],"crossReferences":{"DailyMed":["dabigatran%20etexilate%20mesylate"],"PubChem":["170466107"],"Wikipedia":["Dabigatran"],"drugbank":["DB06695"],"chEBI":["70746"]},"childChemblIds":["CHEMBL1615369"],"count":12,"approvedIndications":["MONDO_0000831","HP_0004419"],"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003095","HP_0000726","EFO_0001645","EFO_0004286","HP_0001907","HP_0000083","HP_0001871","MONDO_0000831","EFO_0003827","EFO_0000712","EFO_0003884","EFO_0000673","EFO_1000652","EFO_0003907","HP_0004419","HP_0004936"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for recurrent thrombophlebitis and thrombotic disease and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL563168","canonicalSmiles":"CCNC(=O)c1cc2c(-c3ccc(Cl)cc3Cl)nc(N)nc2s1","inchiKey":"YPEOXUOUTBMBCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL563168","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08789"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL568737","canonicalSmiles":"CC(C)CC(=O)O","inchiKey":"GWYFCOCPABKNJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLBUTANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Methylbutanoate","Isovaleric Acid"],"crossReferences":{"PubChem":["144208802"],"Wikipedia":["3-Methylbutanoic_acid"],"drugbank":["DB03750"],"chEBI":["28484"]},"childChemblIds":["CHEMBL1762642"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL571700","canonicalSmiles":"CN(C)C(=S)SC(=S)N(C)C","inchiKey":"REQPQFUJGGOFQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205209","144208752","144213197","170465567","26754501","29215363"],"drugbank":["DB14178"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL582878","canonicalSmiles":"O=C(O)CCCc1c[nH]c2ccccc12","inchiKey":"JTEDVYBZBROSJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOLE-3-BUTYRIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indole-3-Butyric Acid"],"crossReferences":{"PubChem":["144211604","174006785","26757715"],"Wikipedia":["Indole-3-butyric_acid"],"drugbank":["DB02740"],"chEBI":["33070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL593125","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](F)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"OAPPZHVTNHJVAL-JZMIEXBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593125","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04097"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL622","canonicalSmiles":"CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3","inchiKey":"NNYBQONXHNTVIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ETODOLAC","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ebretin","Etodolac","Etolyn","Etopan xl","Lodine","Lodine sr","Lodine xl","Ramodar"],"synonyms":["AY-24,236","AY-24-236","AY-24236","Etodolac","Etodolic acid","NIH-9918","NSC-282126"],"crossReferences":{"DailyMed":["etodolac"],"PubChem":["144209416","170464915","174007213","50105240","56422166","85231029","855612","90340662"],"Wikipedia":["Etodolac"],"drugbank":["DB00749"],"chEBI":["4909"]},"count":10,"approvedIndications":["EFO_0000685","EFO_0002506","EFO_0003843","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0002970","EFO_0000685","EFO_0002506","Orphanet_79292","EFO_0003860","EFO_0009582","EFO_0000182","EFO_0004142","HP_0003419","EFO_0003843","EFO_0005755"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL643","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccccc21)N(C)C","inchiKey":"PWWVAXIEGOYWEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROMETHAZINE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-30321","Phenergan","Promethacon","Promethazine","Promethegan","RP-3277","Remsed","Zipan-25","Zipan-50"],"crossReferences":{"DailyMed":["promethazine%20hydrochloride"],"PubChem":["104171211","124881100","124881103","144203778","170465107","26752304","50105224","90341785"],"TG-GATEs":["110"],"Wikipedia":["Promethazine"],"drugbank":["DB01069"],"chEBI":["8461"]},"childChemblIds":["CHEMBL1200750"],"count":15,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0005296","HP_0000726","EFO_1000948","MONDO_0004900","EFO_0004698","EFO_1000971","EFO_0003843","EFO_0000384","HP_0002018","MONDO_0002050","EFO_0004888","EFO_0005295","HP_0003419","HP_0002013","EFO_1001188","EFO_0005230","EFO_0000692","EFO_0003785"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and is indicated for pruritus and allergy and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL75880","canonicalSmiles":"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1","inchiKey":"CYXKNKQEMFBLER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERHEXILINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," United Kingdom"],"classes":["Hepatotoxicity"," Neurotoxicity"],"year":1985},"tradeNames":[],"synonyms":["Perhexiline"],"crossReferences":{"PubChem":["174006795"],"TG-GATEs":["45"],"Wikipedia":["Perhexiline"],"drugbank":["DB01074"],"chEBI":["35553"]},"childChemblIds":["CHEMBL1334033"],"count":5,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000205560","ENSG00000198793","ENSG00000157184"],"count":3},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000319","EFO_0000538","EFO_1001458","EFO_1000899"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for cardiovascular disease and has 4 investigational indications. It was withdrawn in Spain and  United Kingdom initially in 1985 due to Hepatotoxicity and  Neurotoxicity."}
{"id":"CHEMBL76725","canonicalSmiles":"N=C(N)NCC1COc2ccccc2O1","inchiKey":"HIUVKVDQFXDZHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOXAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanoxan"],"crossReferences":{"PubChem":["144205384","29216144"],"drugbank":["DB13211"]},"childChemblIds":["CHEMBL1742462"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL85231","canonicalSmiles":"CN(C)CC(Oc1ccccc1)Oc1ccccc1","inchiKey":"QNMGHBMGNRQPNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDIFOXAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Medifoxamine"],"crossReferences":{"drugbank":["DB13219"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL8946","canonicalSmiles":"CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O","inchiKey":"AADCDMQTJNYOSS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETICLOPRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eticlopride"],"crossReferences":{"PubChem":["11112879","26755017"],"Wikipedia":["Eticlopride"],"drugbank":["DB15492"]},"childChemblIds":["CHEMBL1256917"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL92963","canonicalSmiles":"C=C(Br)CC1(C(C)C)C(=O)NC(=O)N(C)C1=O","inchiKey":"WGMASVSHOSNKMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARCOBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Narcobarbital"],"crossReferences":{"Wikipedia":["Narcobarbital"],"drugbank":["DB13229"],"chEBI":["81294"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93","canonicalSmiles":"CC(c1cc2ccccc2s1)N(O)C(N)=O","inchiKey":"MWLSOWXNZPKENC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZILEUTON","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zyflo","Zyflo cr"],"synonyms":["A-64077","ABBOTT-64077","Zileuton"],"crossReferences":{"DailyMed":["zileuton"],"PubChem":["144205233","144211465","170465222","174007276","26719885","29215400"],"Wikipedia":["Zileuton"],"drugbank":["DB00744"],"chEBI":["10112"]},"count":9,"approvedIndications":["EFO_0000270"],"linkedTargets":{"rows":["ENSG00000012779"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000339","Orphanet_232","EFO_0000270","EFO_0000768","MONDO_0008903","EFO_0003768","EFO_0000341","EFO_0003894"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for asthma and has 8 investigational indications."}
